Skip to main content


15 April 2024 • Hotel Adlon Kempinski Berlin

Berlin Talman Global Investment Forum Schedule

2024 Schedule TBA

Monday, 15 April 2024

  • 10:00

    Talman Global Investment Forum Introduction

Alex Rogers, Executive Producer of the International Cannabis Business Conference, welcomes Berlin GIF conference attendees and provides an overview of the conference schedule, including the panels and speakers that will be providing presentations and interviews. Ngaio Bealum will be the Master of Ceremonies.

  • 10:15

    Keynote TBA

  • 10:30

    Bridging the Gap Between the Public and Private Sectors

Creating partnerships to push the cannabis R&D sector forward

Governments around the world have historically prohibited cannabis and those prohibition policies have created a significant gap between the public and private sectors as it pertains to the emerging cannabis industry. For the cannabis industry to reach its full potential, and in the process, help governments achieve their goal of eliminating the unregulated market, public entities need to form partnerships with private cannabis companies. Public private partnerships are especially vital for cannabis research and development, which is the backbone of the emerging global industry, particularly in the medical sector. Panelists will discuss what public private partnerships involve, as well as what types of public entities are best suited for such partnerships.

  • 11:15

    Policy Modernization in Slovenia

The hidden gem of cannabis R&D

Slovenia is already one of the top international research and development hubs for multiple large industries, including the global pharmaceutical industry. Home to some of the best academic institutions on earth, Slovenia already possesses the necessary knowledge and facility resources to become the world’s top destination for cannabis research and development efforts. A coalition of leading policy and industry advocates are working diligently to achieve policy modernizations in Slovenia that will yield sensible regulations for cannabis R&D. Panelists will provide an overview of current efforts in Slovenia, in addition to providing examples to demonstrate why Slovenia is poised to become a top international cannabis R&D hub.

  • 12:00

    Are You Ready For An Investor?

Business planning & fundraising fundamentals

Due to the current capital-stressed economic environment, understanding what an investor is looking for in an investment opportunity and being prepared to present a viable business proposition have become critical to any startup’s ability to secure capital. While the cannabis industry remains a high-growth sector with increasing interest from investors looking to hedge against diminishing returns in other mature sectors, the level of due diligence and general  expectations of new and more sophisticated investors entering the space is higher than ever. Introducing a market-validated value proposition, backed by a solid business plan, and presented via a polished investment deck, is fundamental to any successful capital raise. This one-hour interactive seminar introduces the fundamental questions that sophisticated investors seek answers to and how entrepreneurs should prepare in today’s highly competitive global capital market.

  • 13:00


  • 14:00

    Core market developments in Germany and greater Europe

Exploring potential opportunities in Europe’s expanding cannabis industry

This presentation will focus on the economic opportunities for cannabis in Germany and the broader EU market. It will present data on total addressable markets and supply and demand expectations in the early years of legalization. It will also examine commonalities in policy and potential market entry strategies for cannabis operators. There is a lot of potential, for those with focus and discipline.

  • 14:45

    Bio-Tech and Drug Development

Developing narrowly tailored pharmaceutical products for evolving demand

Medical cannabis products exist in several forms, ranging from products involving raw flower material to pharmaceutical-grade products derived from the cannabis plant. As research continues to unlock more knowledge about cannabinoids and other compounds contained in the cannabis plant, medical product developers in the biotech sector will have more options to consider when creating cannabis-derived medications. Panelists will discuss the current state of the cannabis biotech sector, what types of products patients can expect in the future, in addition to emerging medication delivery methods and strategies.

  • 15:30

    Cutting-Edge Hemp Technologies

Exploring “The Real Green Economy”

The global hemp industry is creating significant opportunities for entrepreneurs and investors, particularly in the areas of hemp-based scientific research and technology development. In many ways, public policies and regulations are more favorable for hemp products and research compared to endeavors involving non-hemp varieties of cannabis. Those increased freedoms yield an operable landscape that is more conducive to harnessing technology and innovation, which is why some of the most cutting-edge agriculture technology is often found in the hemp industry. Expert panelists will discuss what types of leading technologies are being developed in the hemp industry, the economic trends and potential of the global hemp industry, and what industry members can expect to see in the future.

  • 16:20